bluebird bio Inc (NASDAQ:BLUE)

159.49
Delayed Data
As of Jul 27
 +0.58 / +0.36%
Today’s Change
29.73
Today|||52-Week Range
197.35
+73.89%
Year-to-Date

Today’s Trading

Previous close158.91
Today’s open157.79
Day’s range-- - --
Volume423,516
Average volume (3 months)946,942
Market cap$5.7B
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+9.41%
Earnings growth (this year)-71.95%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales95.78
Price/Book10.46

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp-2.29-4.03%
JUNOJuno Therapeutics In...-2.36-4.70%
CTLTCatalent Inc+1.52+5.05%
NVAXNovavax Inc-0.17-1.44%
Data as of 07/27/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$25.4M
Annual profit (last year)-$48.7M
Net profit margin-191.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers